Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention

Author:

Latif Faisal12,Uyeda Lauren3,Edson Robert3,Bhatt Deepak L.456,Goldman Steven7,Holmes David R.8,Rao Sunil V.9,Shunk Kendrick10,Aggarwal Kul1112,Uretsky Barry1314,Bolad Islam1516,Ziada Khaled17,McFalls Edward1819,Irimpen Anand2021,Truong Huu Tam22,Kinlay Scott3,Papademetriou Vasilios2324,Velagaleti Raghava S.4,Rangan Bavana V.25,Mavromatis Kreton2627,Shih Mei-Chiung3,Banerjee Subhash2829,Brilakis Emmanouil S.253031

Affiliation:

1. VA Medical Center, Oklahoma City (F.L.).

2. University of Oklahoma, Oklahoma City (F.L.).

3. VA Cooperative Studies Program Coordinating Center, Mountain View, CA (L.U., R.E., M.-C.S.).

4. VA Boston Healthcare System, MA (D.L., S.K., R.S.V).

5. Brigham and Women’s Hospital Heart & Vascular Center, Boston, MA (D.L.B.).

6. Harvard Medical School, Boston, MA (D.L.B.).

7. University of Arizona Sarver Heart Center, Tucson (S.G.).

8. Mayo Clinic, Rochester, MN (D.R.H.).

9. Durham VA Medical Center, NC (S.V.R.).

10. San Francisco VA Medical Center, CA (K.S.).

11. Harry S Truman VA Hospital, Columbia, MO (K.A.).

12. University of Missouri Healthcare, Columbia (K.A.).

13. Central Arkansas Veterans Health System, Little Rock (B.U.).

14. University of Arkansas for Medical Sciences, Little Rock (B.U.).

15. Indiana University School of Medicine, Indianapolis (I.B.).

16. Roudebush VA Medical Center, Indianapolis, Indiana (I.B.).

17. University of Kentucky, Lexington (K.Z.).

18. VA Medical Center, Minneapolis, MN (E.M.).

19. University of Minnesota, Minneapolis (E.M.).

20. Southeast Louisiana Veterans Health Care System, New Orleans (A.I.).

21. Tulane University Heart and Vascular Institute, New Orleans, LA (A.I.).

22. VA Loma Linda Medical Center, CA (H.T.T.).

23. VA Medical center Washington DC (V.P.).

24. Georgetown University, Washington DC (V.P.).

25. Minneapolis Heart Institute Foundation, MN (B.V.R., E.S.B.).

26. Atlanta VA Healthcare System, GA (K.M.).

27. Emory University, Atlanta, GA (K.M.).

28. Dallas VA Medical Center, TX (S.B.).

29. University of Texas Southwestern Medical Center, Dallas (S.B.).

30. Minneapolis Heart Institute, MN (E.S.B.).

31. Abbott Northwestern Hospital, Minneapolis, MN (E.S.B.).

Abstract

Background: Direct stenting without pre-dilation or post-dilation has been advocated for saphenous vein graft percutaneous coronary intervention to decrease the incidence of distal embolization, periprocedural myocardial infarction, and target lesion revascularization. Methods: We performed a post hoc analysis of patients enrolled in the DIVA (Drug-Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Angioplasty; NCT 01121224) prospective, double-blind, randomized controlled trial. Patients were stratified into stent-only and balloon-stent groups. Primary end point was 12-month incidence of target vessel failure (defined as the composite of cardiac death, target vessel myocardial infarction, or target vessel revascularization). Secondary end points included all-cause death, stent thrombosis, myocardial infarction, and target lesion revascularization during follow-up. Results: Of the 575 patients included in this substudy, 185 (32%) patients underwent stent-only percutaneous coronary intervention. Patients in the stent-only versus balloon-stent group had similar baseline characteristics and similar incidence of target vessel failure at 12-months (15% versus 19%; hazard ratio, 1.34 [95% CI, 0.86–2.08]; P =0.19). During long-term follow-up (median of 2.7 years), the incidence of definite stent thrombosis (1% versus 5%; hazard ratio, 9.20 [95% CI, 1.23–68.92]; P =0.0085), the composite of definite or probable stent thrombosis (5% versus 11%; hazard ratio, 2.52 [95% CI, 1.23–5.18]; P =0.009), and target vessel myocardial infarction (8% versus 14%; hazard ratio, 1.92 [95% CI, 1.08–3.40]; P =0.023) was lower in the stent-only group. Multivariable analysis showed that a higher number of years since coronary artery bypass grafting and >1 target saphenous vein graft lesions were associated with increased target vessel failure during entire follow-up, while preintervention Thrombolysis in Myocardial Infarction-3 flow was protective. Conclusions: In patients undergoing percutaneous coronary intervention of de novo saphenous vein graft lesions, there was no difference in target vessel failure at 12 months and long-term follow-up in the stent-only versus the balloon-stent group; however, the incidence of stent thrombosis was lower in the stent-only group, as was target vessel myocardial infarction. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT 01121224.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3